Female health is a critical area that often goes under-addressed. Those with important or chronic concerns, from infertility to conditions like Polycystic Ovary Syndrome (PCOS) or Endometriosis, are given the choice of suffering in silence or agreeing to strong medical treatments with few intermediary therapeutic options available.
Gynov is seeking to fill that gap with qualitative dietary supplements that complement medical treatment through a combination of stringent scientific research and holistic medicine.
A great example of this is the company’s flagship product, Gynositol, which helps with the common female health condition of PCOS.
“PCOS is a major endocrine disorder and the number one cause of woman’s infertility,” said Pierre-Yves Mousset, CEO and Co-Founder, Gynov. “Its pathophysiology isn’t fully understood but we’re aware that it’s associated with a urinary leak of inositols. After years of debate about the best form of inositol to provide to women with PCOS, it is now clear that only Myo-inositol, chosen by Gynov, should be considered.”
In response, Gynositol helps women manage PCOS by replenishing their Myo-inositol levels. This helps with the proper functioning of cells. As a result, it can restore ovarian function, improve oocyte quality and, critically, reduce insulin resistance as well as the incidence and severity of gestational diabetes.
Click below to share this article